Role of HOS in cell transformation and apoptosis
Role of HOS in cell transformation and apoptosis
批准号:
6404630
负责人:
Serge Y Fuchs
金额:
$24.62万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2005-02-28
中文摘要
在研究靶向蛋白质的机制,
Fuks博士通过泛素化,确定了HOS,一种果蝇Slimb的人类同源物
蛋白,作为SCF E3泛素连接酶募集的关键因素,
磷酸化底物,包括I-κ-B和β-连环蛋白。他们有
证明了HOS功能的改变会影响这些细胞的稳定性,
蛋白质和NF-κ-B-和Tcf依赖性转录输出。他们的
初步数据还显示,HOS在人类肿瘤细胞系中过表达
以及在正常细胞中,
有丝分裂原和致癌Ras。他们的工作假设是,
它能够识别磷酸化底物并将其靶向
SCF-Roc 1依赖的泛素化,是一种重要的细胞调节因子,
增殖、恶性转化和程序性细胞死亡。他们提出
描述底物识别和SCF的机制和要求
招聘HOS他们的第二个目的是了解如何监管居屋,
人体细胞他们将分析HOS如何通过其表达进行调节,
稳定性和酪氨酸磷酸化。最后,他们将探讨
HOS在调节HOS底物的细胞功能中的作用(I?B和
根据细胞生长和转化的变化,
程序性细胞死亡总之,拟议的研究将提供新的
了解HOS功能,其在人类肿瘤发生中的作用,
HOS作为假定的治疗靶点。
英文摘要
In studying the mechanisms of targeting proteins for
ubiquitination, Dr. Fuks identified HOS, a human homologue of Drosophila Slimb
protein, as a key factor in recruitment of SCF E3 ubiquitin ligase to
phosphorylated substrates including I-kappa-B and beta-catenin. They have
demonstrated that alteration of HOS function affects stability of these
proteins and NF-kappa-B- and Tcf-dependent transcriptional output. Their
preliminary data also show that HOS is overexpressed in human tumor cell lines
and primary human and mouse tumors as well as in normal cells in response to
mitogens and oncogenic Ras. It is their working hypothesis that HOS, through
its ability to recognize phosphorylated substrates and target them for
SCF-Roc1-dependent ubiquitination, is an important regulator of cell
proliferation, malignant transformation and programmed cell death. They propose
to delineate the mechanisms and requirements for substrate recognition and SCF
recruitment by HOS. Their second goal is to find out how HOS is regulated in
human cells. They will analyze how HOS is regulated via its expression,
stability and tyrosine phosphorylation. Finally, they will explore the role of
HOS in modulation of the cellular functions of HOS substrates (I?B and
beta-catenin) as per the changes in cell growth and transformation, and the
programmed cell death. In all, the proposed studies will provide new
understanding of HOS function, its role in human tumorigenesis and characterize
HOS as a putative therapeutic target.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Type I Interferon Pathway in Pancreatic Adenocarcinoma
-
批准号:10596486
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2020
-
负责人:Serge Y Fuchs
-
依托单位:
Type I Interferon Pathway in Pancreatic Adenocarcinoma
-
批准号:10374027
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2020
-
负责人:Serge Y Fuchs
-
依托单位:
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy
-
批准号:10333372
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2020
-
负责人:Serge Y Fuchs
-
依托单位:
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy
-
批准号:10573175
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2020
-
负责人:Serge Y Fuchs
-
依托单位:
Negative regulation of myeloid-derived suppressive cells in cancer
-
批准号:10316256
-
项目类别:
-
资助金额:$46.18万
-
财政年份:2017
-
负责人:Serge Y Fuchs
-
依托单位:
Project 3- Integrated Stress and Interferon Responses
-
批准号:10017915
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2013
-
负责人:Serge Y Fuchs
-
依托单位:
Project 3- Integrated Stress and Interferon Responses
-
批准号:10247664
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2013
-
负责人:Serge Y Fuchs
-
依托单位:
UPR, interferon signaling and tumorigenesis
-
批准号:8596374
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2013
-
负责人:Serge Y Fuchs
-
依托单位:
Interferon Responses in Myeloid Leukemia
-
批准号:8448756
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2010
-
负责人:Serge Y Fuchs
-
依托单位:
Interferon Responses in Myeloid Leukemia
-
批准号:8105113
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2010
-
负责人:Serge Y Fuchs
-
依托单位:
Interferon Responses in Myeloid Leukemia
-
批准号:8657855
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2010
-
负责人:Serge Y Fuchs
-
依托单位:
Interferon Responses in Myeloid Leukemia
-
批准号:8005927
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2010
-
负责人:Serge Y Fuchs
-
依托单位:
Interferon Responses in Myeloid Leukemia
-
批准号:8259399
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2010
-
负责人:Serge Y Fuchs
-
依托单位:
Regulation of interferon receptor by Leishmania kinase
-
批准号:7318725
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2007
-
负责人:Serge Y Fuchs
-
依托单位:
Regulation of interferon receptor by Leishmania kinase
-
批准号:7455811
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2007
-
负责人:Serge Y Fuchs
-
依托单位:
Stability of prolactin receptor and prolactin signaling
-
批准号:7254227
-
项目类别:
-
资助金额:$25.57万
-
财政年份:2006
-
负责人:Serge Y Fuchs
-
依托单位:
Stability of prolactin receptor and prolactin signaling
-
批准号:7866566
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2006
-
负责人:Serge Y Fuchs
-
依托单位:
Stability of prolactin receptor and prolactin signaling
-
批准号:7631243
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2006
-
负责人:Serge Y Fuchs
-
依托单位:
Stability of prolactin receptor and prolactin signaling
-
批准号:7421073
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2006
-
负责人:Serge Y Fuchs
-
依托单位:
Stability of prolactin receptor and prolactin signaling
-
批准号:7141523
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2006
-
负责人:Serge Y Fuchs
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: